Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior

Background: To “limit the risk of abuse and misuse” and “encourage correct usage”, the French drug regulatory authority stated that—from April 2017—zolpidem prescription must be performed on a secured prescription pad. This national study aims to evaluate the perception of general practitioners (GPs...

Full description

Bibliographic Details
Main Authors: Edouard-Jules Laforgue, Marion Istvan, Benoit Schreck, Marie Mainguy, Pascale Jolliet, Marie Grall-Bronnec, Caroline Victorri-Vigneau
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/8/2176
_version_ 1797445673950380032
author Edouard-Jules Laforgue
Marion Istvan
Benoit Schreck
Marie Mainguy
Pascale Jolliet
Marie Grall-Bronnec
Caroline Victorri-Vigneau
author_facet Edouard-Jules Laforgue
Marion Istvan
Benoit Schreck
Marie Mainguy
Pascale Jolliet
Marie Grall-Bronnec
Caroline Victorri-Vigneau
author_sort Edouard-Jules Laforgue
collection DOAJ
description Background: To “limit the risk of abuse and misuse” and “encourage correct usage”, the French drug regulatory authority stated that—from April 2017—zolpidem prescription must be performed on a secured prescription pad. This national study aims to evaluate the perception of general practitioners (GPs) towards this new regulation and its link with prescription strategies. Methods: We conducted structured interviews of GPs. Data were collected about GPs’ perception of the measure and therapeutic strategies towards zolpidem. The primary outcome was the description of the GPs’ strategy of prescription, based on the perception towards the new regulation for zolpidem. Results: For 206 GPs, the new regulation was mainly perceived as helpful (61%) and as a difficulty (55%). Other perceptions were the awareness of the risks of zolpidem (18%), awareness of the risks of hypnotics (13%), and nothing changed (5%). Four clusters of GPs were identified. In the clusters with the perception as a difficulty (only or associated with helpful), the GPs who applied the strategy “no modification” for >50% of their patients were more frequently compared to awareness and helpful only clusters (60.8%; 42.9%; 20.4%; 26.7%) (<i>p</i> < 0.001). Conclusions: We highlighted an association between the perception of the new regulation of zolpidem prescription by GPs and a strategy of prescription.
first_indexed 2024-03-09T13:30:10Z
format Article
id doaj.art-6771663d14514cd181f74caf51fab722
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T13:30:10Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-6771663d14514cd181f74caf51fab7222023-11-30T21:19:28ZengMDPI AGJournal of Clinical Medicine2077-03832022-04-01118217610.3390/jcm11082176Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription BehaviorEdouard-Jules Laforgue0Marion Istvan1Benoit Schreck2Marie Mainguy3Pascale Jolliet4Marie Grall-Bronnec5Caroline Victorri-Vigneau6Nantes Université, CHU Nantes, Service de Pharmacologie Clinique—Centre d’Évaluation et d’Information sur la Pharmacovigilance-Addictovigilance, F-44000 Nantes, FranceNantes Université, CHU Nantes, Service de Pharmacologie Clinique—Centre d’Évaluation et d’Information sur la Pharmacovigilance-Addictovigilance, F-44000 Nantes, FranceNantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients-Centered Outcomes and HEalth Research, SPHERE, F-44000 Nantes, FranceNantes Université, CHU Nantes, Service de Pharmacologie Clinique—Centre d’Évaluation et d’Information sur la Pharmacovigilance-Addictovigilance, F-44000 Nantes, FranceNantes Université, CHU Nantes, Service de Pharmacologie Clinique—Centre d’Évaluation et d’Information sur la Pharmacovigilance-Addictovigilance, F-44000 Nantes, FranceNantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients-Centered Outcomes and HEalth Research, SPHERE, F-44000 Nantes, FranceNantes Université, CHU Nantes, Service de Pharmacologie Clinique—Centre d’Évaluation et d’Information sur la Pharmacovigilance-Addictovigilance, F-44000 Nantes, FranceBackground: To “limit the risk of abuse and misuse” and “encourage correct usage”, the French drug regulatory authority stated that—from April 2017—zolpidem prescription must be performed on a secured prescription pad. This national study aims to evaluate the perception of general practitioners (GPs) towards this new regulation and its link with prescription strategies. Methods: We conducted structured interviews of GPs. Data were collected about GPs’ perception of the measure and therapeutic strategies towards zolpidem. The primary outcome was the description of the GPs’ strategy of prescription, based on the perception towards the new regulation for zolpidem. Results: For 206 GPs, the new regulation was mainly perceived as helpful (61%) and as a difficulty (55%). Other perceptions were the awareness of the risks of zolpidem (18%), awareness of the risks of hypnotics (13%), and nothing changed (5%). Four clusters of GPs were identified. In the clusters with the perception as a difficulty (only or associated with helpful), the GPs who applied the strategy “no modification” for >50% of their patients were more frequently compared to awareness and helpful only clusters (60.8%; 42.9%; 20.4%; 26.7%) (<i>p</i> < 0.001). Conclusions: We highlighted an association between the perception of the new regulation of zolpidem prescription by GPs and a strategy of prescription.https://www.mdpi.com/2077-0383/11/8/2176zolpidemdrug regulationperceptiongeneral practitionerprescription behavior
spellingShingle Edouard-Jules Laforgue
Marion Istvan
Benoit Schreck
Marie Mainguy
Pascale Jolliet
Marie Grall-Bronnec
Caroline Victorri-Vigneau
Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior
Journal of Clinical Medicine
zolpidem
drug regulation
perception
general practitioner
prescription behavior
title Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior
title_full Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior
title_fullStr Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior
title_full_unstemmed Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior
title_short Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior
title_sort perception of the regulatory change for zolpidem prescription by french general practitioners and its relation to prescription behavior
topic zolpidem
drug regulation
perception
general practitioner
prescription behavior
url https://www.mdpi.com/2077-0383/11/8/2176
work_keys_str_mv AT edouardjuleslaforgue perceptionoftheregulatorychangeforzolpidemprescriptionbyfrenchgeneralpractitionersanditsrelationtoprescriptionbehavior
AT marionistvan perceptionoftheregulatorychangeforzolpidemprescriptionbyfrenchgeneralpractitionersanditsrelationtoprescriptionbehavior
AT benoitschreck perceptionoftheregulatorychangeforzolpidemprescriptionbyfrenchgeneralpractitionersanditsrelationtoprescriptionbehavior
AT mariemainguy perceptionoftheregulatorychangeforzolpidemprescriptionbyfrenchgeneralpractitionersanditsrelationtoprescriptionbehavior
AT pascalejolliet perceptionoftheregulatorychangeforzolpidemprescriptionbyfrenchgeneralpractitionersanditsrelationtoprescriptionbehavior
AT mariegrallbronnec perceptionoftheregulatorychangeforzolpidemprescriptionbyfrenchgeneralpractitionersanditsrelationtoprescriptionbehavior
AT carolinevictorrivigneau perceptionoftheregulatorychangeforzolpidemprescriptionbyfrenchgeneralpractitionersanditsrelationtoprescriptionbehavior